IL23 Cancer Research Results
IL23, Interleukin 23: Click to Expand ⟱
| Source: |
| Type: |
A heterodimeric cytokine composed of an IL-12B subunit and an IL-23A subunit. IL-23 is part of the IL-12 family of cytokines.
IL-23 is an inflammatory cytokine. IL-23 is overexpressed in a number of cancer types.
|
Arthritis, Arthritis: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
BMD↑, Cartilage↑, IL17↓, IL22↓, IL23↓, IL28↓, CD4+↓, CD8+↓, LAMB3↑, COL4↓, THBS2↓, ITGA11↓, PPARγ↑, ACAA1↓, PLIN1↓, FABP4↓, PCK1↓, UCP1↓, TNF-α↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics ⓘ
UCP1↓, 1,
Core Metabolism/Glycolysis ⓘ
ACAA1↓, 1, FABP4↓, 1, PCK1↓, 1, PLIN1↓, 1, PPARγ↑, 1,
Migration ⓘ
Cartilage↑, 1, COL4↓, 1, ITGA11↓, 1, LAMB3↑, 1, THBS2↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↓, 1, IL17↓, 1, IL22↓, 1, IL23↓, 1, IL28↓, 1, TNF-α↓, 1,
Clinical Biomarkers ⓘ
BMD↑, 1,
Infection & Microbiome ⓘ
CD8+↓, 1,
Total Targets: 19
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: IL23, Interleukin 23
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:35 Cells:% prod#:% Target#:543 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page